Background. Pathogenic Escherichia coli strains are a common cause of intestinal and extra-intestinal infections, especially in developing countries. Extended spectrum beta-lactamases (ESBL S ), a heterogeneous group of plasmidencoded beta-lactamases, are common throughout the world. Objectives. The aim of the present study was to determine the phenotypic and genotypic characteristics of ESBL S produced by E. coli isolates taken from patients with diarrhea and urinary tract infections (UTI) in northwest Iran. Material and Methods. A total of 132 E. coli isolates (92 isolates from UTI and 40 isolates from diarrheic cases) were recovered and confirmed by biochemical tests. The isolates were examined for bla TEM and bla SHV genes and phylogenetic background by two multiplex PCR assays. The isolates were tested for antibiotic susceptibility against nine antibiotic agents by the disk diffusion method. Results. The phylogenetic analysis showed that the UTI isolates mostly fell into phylo-group B2, followed by D, while the diarrheic isolates belonged to phylo-groups D and A. Out of 92 UTI isolates, 29.3% and 17.4% possessed bla TEM and bla SHV genes, respectively. Ten diarrheic isolates were positive for bla TEM, two isolates possessed the bla SHV gene, and one isolate was positive for both genes. The UTI isolates that were positive for bla TEM and bla SHV genes mostly belonged to phylo-groups D and B2, whereas the diarrhea isolates were in phylo-groups D and A. Phylogenetic group D isolates have an accumulation of ESBL S genes in the diarrheic and UTI isolates. In both the UTI and diarrhea isolates, the maximum rate of resistance was against cefazolin, and the minimum rate of resistance was against nitrofurantoin. Twenty-four antibiotic resistance patterns were observed among the isolates. The amikacin, ciprofloxacin, cefotaxime, cefuroxime, cefazolin, gentamicin, nalidixic acid and trimethoprim/sulfamethoxazole resistance pattern was the most prevalent in the isolates that belonged to phylo-group D. Conclusions. The correct choice of effective antibiotic policy is needed to limit the spread of antibiotic resistance in bacteria (Adv Clin Exp Med 2014, 23, 4, 523-529).
Escherichia coli (E. coli) strains are versatile bacteria, comprising harmless commensal bacteria as well as different pathogenic variants with the ability to cause both intestinal and extra-intestinal diseases in humans and other hosts [1] . Some strains have specific virulence attributes, which confer the ability to adapt to new niches and cause a broad spectrum of diseases [2] . Several variants have been described, and the strains capable of causing infection of the gastrointestinal system are called intestinal pathogenic E. coli, while those that cause infections outside the gastrointestinal system are called extra-intestinal pathogenic E. coli (ExPEC) [3] . The most frequently reported extra-intestinal diseases caused by ExPEC are urinary tract infections (UTI); other neonatal diseases include meningitis, septicemia, nosocomial pneumonia, cholecystitis, peritonitis, osteomyelitis and infectious arthritis [4, 5] . Diarrheagenic E. coli strains (DEC) are among the most important bacterial enteric pathogens, and are classified into six categories, including enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), and diffusely adhering E. coli (DAEC) [6] . Pathogenic E. coli isolates have a relatively high potential for developing resistance, so the treatment of E. coli infections is becoming increasingly difficult [7] . There are several mechanisms of drug resistance; one of the most important resistant mechanisms is the production of beta-lactamases [8] . Beta-lactamase enzymes hydrolyze the four-membered beta-lactam ring common to a wide range of betalactam type antibiotics [9] .
Among the clinically bacterial isolates, bla TEM , bla SHV and bla CTX-M are the most frequently reported extended-spectrum beta-lactamase (ESBL) genes [10] . E. coli and Klebsiella pneumoniae (K. pneumoniae) are common species of Enterobacteriacae that both have pathogenic potential and frequently incorporate ESBL-encoding genes [11] .
There are four well-recognized phylogroups of E. coli strains and these have been designated A, B1, B2 and D. These groups can be divided into six phylogenetic subgroups including (A 0 , A 1 , B2 2 , B2 3 , D 1 , and D 2 ), according to the combination of the three genetic markers chuA, yjaA and DNA fragment TspE4.C2 [12] . Phylogenetic group distribution may be related to antimicrobial resistance prevalence in isolates of E. coli [13] .
The aim of this study was to determine the bla TEM and bla SHV genes, phylogenetic background and antibiotic resistance profile of E. coli isolates from diarrhea and UTI samples in the Hamadan province in northwest Iran.
Material and Methods

Sampling and Bacteriological Examinations
The study was carried out on 92 UTI samples and 40 diarrhea specimens from patients referred to laboratories in Hamadan, in northwest Iran. The samples were obtained from patients aged between one and 65 years old. They were collected between April and November 2012. The specimens were cultivated on 5% sheep blood agar and MacConkey agar plates (Biolife Laboratories, Milano, Italy). The isolates were confirmed to be E. coli based on colony morphology, gram stain and standard biochemical methods. A single colony was obtained from each sample. Cultures of each isolate confirmed as E. coli were maintained in Luria-Bertani broth (Invitrogen, Paisley, Scotland) with 30% sterile glycerol at -80°C.
Polymerase Chain Reaction (PCR) and Reference Strains
DNA was extracted from the E. coli isolates and reference strains by the lysis method. The E. coli reference strain ECOR62 (chuA+, yjaA+ and Tspe4. C2+), ATCC E. coli 35218 strain (bla TEM +) and K. pneumoniae 700603 strain (bla SHV +) were used as positive controls. E. coli strain ATCC 25922 was used as a negative control. The PCR primers specific for bla TEM and bla SHV were described by Sharma et al. [14] ; phylogenetic groups (A, B1, B2 and D) were described by Clermont et al. [15] . Classification of the isolates in to phylogenetic subgroups (A 0 , A 1 , B2 2 , B2 3 , D 1 and D 2 ) was undertaken as described by Escobar-Paramo et al. [12] . The sequences and sizes of the PCR products are shown in Table 1 . 
Antimicrobial Susceptibility Test
The antibiotic resistance of all the isolates to nine antibacterial agents was assessed by the disk diffusion method according to the Clinical and Laboratory Standards Institute's guidelines [16] . The antibiotic disks (Mast, England) used in this study were amikacin (30 μg), cefazolin (30 μg), cefotaxime (30 μg), cefuroxime (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), nalidixic acid (30 μg), nitrofurantoin (300 μg) and trimethoprim/sulfamethoxazole (1.25/23.75 μg). E. coli ATCC 25922 was used as the positive control for the disk diffusion test.
Statistical Analysis
The statistical analysis for the descriptive data was carried out using SPSS software, version 17.
Results
Following the bacteriological tests, 132 confirmed E. coli isolates (92 urine samples and 40 diarrhea samples) were chosen for antibiogram and molecular examinations. The isolates were recovered from both female (88) and male (44) patient samples.
The phylogenetic analysis showed that the 132 E. coli isolates segregated into phylogenetic groups A (33.3%), B1 (6.8%), B2 (25%) and D (34.9%). The PCR assays for phylotyping of the 92 UTI E. coli isolates indicated that those isolates fell into 4 phylogenetic groups: 23 of them belonged to A (25%), 8 Table 2 ).
The genotyping of the E. coli isolates revealed that out of 92 UTI isolates and 40 diarrheic isolates, 56 (42.4%) isolates were positive for the bla TEM and bla SHV genes. Specifically, 37 isolates (28.03%) were positive for bla TEM; 18 (13.6%) were positive for bla SHV genes; and 1 isolate (0.76%) was positive for both genes. Thirteen diarrheic isolates (32.5%) and 43 UTI isolates (47%) contained bla TEM and/or bla SHV genes ( Table 3) . Out of 13 (32.5%) ESBL positive isolates from diarrheic cases, 10 (25%) isolates carried bla TEM genes and 2 (5%) had bla SHV genes, while 1 (2.5%) isolate included both genes. Out of the 43 (47%) ESBL positive isolates from UTI cases, 27 isolates (29.3%) possessed bla TEM genes and 16 (17.4%) had bla SHV genes (Table 3) . The phylotyping of 56 diarrhea and UTI E. coli isolates possessing beta-lactamase genes indicated that these isolates belonged mainly to phylogenetic groups D and B2. The 10 bla TEM positive isolates from diarrheic cases fell into phylogenetic groups A (3 isolates), B1 (1), B2 (2) and D (4); the 27 UTI isolates belonged to phylogenetic groups A (5 isolates), B1 (1), B2 (11) and D (10). Both of the 2 bla SHV positive isolates from diarrheic cases fell into phylogenetic group D; the 16 bla SHV positive UTI isolates belonged to groups A (5 isolates), B1 (2), B2 (3) and D (6). The 1 isolate (0.76%) that was positive for both genes fell into phylogenetic group D (Table 3) .
According to the results of the antibiotic susceptibility test, in the diarrheic isolates the maximum rate of resistance was against cefazolin 97.5% (39 isolates) and the minimum resistance rate was against nitrofurantoin 10% (4 isolates). The rates of resistance to other antibiotics were as follows: cefotaxim 34 (85%), nalidixic acid 25 (62.5%), cefuroxime 24 (60%), cotrimoxazole 20 (50%), amikacin 19 (47.5%), ciprofloxacin 13 (32.5%), and gentamicin 14 (35%). In the UTI isolates the maximum rate of resistance was against cefazolin 95.7% (88 isolates), followed by cefotaxim 87% (80), cotrimoxazole 66% (61), cefuroxime 65.2% (60), nalidixic acid 59% (54), gentamicin 53.3% (49), amikacin 39.1% (36), ciprofloxacin 39.1% (36), and nitrofurantoin 23.9% (22) . The results showed that 24 antibiotic resistance patterns were found among the E. coli isolates. Fourteen antibiotic resistance patterns were detected in the diarrheic isolates. The cefotaxime, cefuroxime, cefazolin, nalidixic acid and trimethoprim/sulfamethoxazole resistance pattern was the most prevalent pattern in the diarrheic isolates that belonged to phylogenetic groups A and D. Among the UTI isolates, 24 antibiotic resistance patterns were detected. The most frequent antibiotic resistance pattern among these isolates was against amikacin, ciprofloxacin, cefotaxime, cefuroxime, cefazolin, gentamicin, nalidixic acid and trimethoprim/sulfamethoxazole, which was observed in phylogenetic group D. Twenty-four antibiotic resistance patterns were determined, distributed among the isolates in the 4 phylogenetic groups (Table 4) .
Discussion
E. coli is one of the principal bacterial pathogen causes of UTIs, enteric infections and systemic infections in humans and other hosts [3] . Diarrheagenic E. coli strains (DECs) are an important cause of diarrhea, especially in developing countries and constitute an important public health problem [6, 17] . Extensive use of antibiotics to treat E. coli infections caused by resistant isolates will increase the problem of resistance [18, 19] . bla TEM and bla SHV genes, which are commonly found in E. coli and K. pneumoniae, confer resistance to a broad spectrum of beta lactam antibiotics and are a significant therapeutic concern for infections caused by many species of gram-negative bacteria [20] [21] [22] [23] . At the same time, the epidemiology of ESBL-producing E coli is complicated and varies among hospitals and countries [24] . There are alarming trends of associated resistance to other classes of antimicrobial drugs among ESBL-producing organisms isolated from the community [25] .
In the current study, antibiotic resistance patterns were studied for E. coli isolates. Resistance was observed to antibiotics in widespread use, such as cefazolin, ciprofloxacin, cotrimoxazole, cefotaxime, gentamicin, amikacin and nalidixic acid. Most of the isolates in the present study were resistant to multiple antibiotic groups. High resistance to common antibiotics has also been reported in previous studies [7, 11, 26] . The present study offers the first characterization of TEM-type and SHV-type ESBL variants produced by E. coli circulating in hospitals in Hamadan (northwest Iran). The progressive spread of ESBL-producing E. coli seems to be caused mainly by the extensive use of broad-spectrum beta-lactam antibiotics in empiric therapy and rapid plasmid mediated distribution of resistance genes between bacterial species [23] . In this study, the bla TEM gene is the most prevalent ESBL, followed by the bla SHV gene. Therefore, it seems that these two genes are appropriate candidates for molecular screening of ESBL positive samples [8] .
Enterobacteriaceae harboring transferable bla TEM , bla CTX-M , bla SHV and bla OXA genes have been reported worldwide in several studies of clinical isolates. Isendahl et al. [11] reported that 32.6% fecal samples from children were carriers of ESBLproducing E. coli or K. pneumonia. Shahid et al. [22] reported findings similar to those of the present study: 38.4% of the isolates in their study were positive for bla genes, and the bla TEM gene was more prevalent than the bla SHV gene. In another study, the prevalence of bla TEM , bla CTX-M and bla SHV genes among E. coli isolates were 100%, 37.5% and 4.1% respectively [24] . The incidence of ESBL-producing isolates from 2002 to 2010 increased from 9.2% to 21.2%. The highest rates were observed in Asia (38.3%) and Latin America (22.9%), and the lowest rates in Africa (6.3%), North America (6%), and the South Pacific (5.8%) [27] . In an investigation on patients with UTI in the capital of Iran (Tehran) a combined disk test indicated that of 109 ESBL-positive isolates, 77 isolates (70.6%) were carrying bla SHV , 75 isolates (68.8%) were carrying bla CTX-M , and 95 isolates (87.1%) were carrying bla TEM genes, while 40 isolates (36.6%) isolates had all three of these genes [8] .
Phylogenetic analyses have shown that extra-intestinal and intestinal E. coli are segregated in four main phylogenetic groups: A, B1, B2, and D [15] . In the present study, UTI isolates fell mostly into phylogenetic group B2, followed by D; and diarrheic isolates belong to groups D and A. Similarly, previous reports indicated that most ExPEC strains belonged to group B2, although some fell into group D [3, 28] . In this study, UTI isolates that were positive for bla TEM and bla SHV genes mostly belonged to phylogenetic groups D and B2, while diarrhea isolates that were positive for these genes were in groups D and A. A study of community-acquired fecal carriage of ESBL-producing E. coli isolates in children showed that phylo-group A predominated and that the most frequent ESBL was CTX-M-1. The CTX-M producing isolates mainly carried one other beta-lactamase-encoding gene (TEM-1 and SHV). Most of the ESBL-producing E. coli isolates belonged to groups A and B1, possibly because of greater antibiotic exposure of group A/B1 strains in the fecal flora [28] . * AK -amikacin, CIP -ciprofloxacin, CTX -cefotaxime, CXM -cefuroxime, CZ -cefazolin, GM -gentamicin, NA -nalidixic acid, NI -nitrofurantoin, TS -trimethoprim/sulfamethoxazole.
In conclusion, as Abdou et al. wrote: "Resistance in gram negative bacteria (such as E. coli) presents a major challenge for the antimicrobial therapy and significantly narrows the treatment options of human infections" [29] . Pathogenic isolates of E. coli have relatively high potentials for developing resistance and can make the treatment of ESBL-producing E. coli infections difficult [7] . Therefore, correctly detecting drug-resistant E. coli is important to prevent the further spread of betalactamase-positive resistance in humans and other hosts [20] . The correct choice of safe and effective antibiotic policy is needed to limit the emergence and spread of antibiotic resistance in bacteria [7] . The present study examined the genes codifying for beta-lactamases, but this does not necessarily reflect the expression of these genes during infection; and the results might not be applicable to areas with a different epidemiology of ESBL-producing strains of E. coli. Discrepancies in the distribution of genotypes of ESBLs may be due to differences in the patterns of antibiotic use in various geographical areas. In addition, frequent surveillance of resistance to antimicrobial agents is necessary.
